1. **Specifications Table** {#s0005}
===========================

TableSubject area*Biology*More specific subject area*Cancer*Type of data*Figure*How data was acquired*Database Oncomine*[@bib1]Data format*Filtered and analyzed*Experimental factors*Not applicable*Experimental features*We query Oncomine for STAT5A and breast cancer*Data source location*Montréal, Québec*Data accessibility*Data is within this article.*

2. **Value of the data** {#s0010}
========================

•We show that in different independent studies STAT5A is downregulated in breast cancer.•The downregulation of STAT5A supports a tumour suppressor role for STAT5A in breast cancer and is consistent with our recent discovery that STAT5A is a p53-target gene [@bib2]•High levels of STAT5A indicate a good prognosis in breast cancer and it assessment can be used in the clinics as part of a multigene prognostic test ([Fig. 1](#f0005){ref-type="fig"}).

3. Data {#s0015}
=======

We show that STAT5A is downregulated in breast cancer using several large-scale gene expression analyses available at Oncomine: <https://www.oncomine.org/resource/main.html> [@bib1].

4. Experimental design, materials and methods {#s0020}
=============================================

We used the publicly available Oncomine search to find the status of STAT5A in breast cancer.

Appendix A. Supplementary material {#s0030}
==================================

Supplementary material

Funded by CIHR to GF ([229774](#gs1){ref-type="funding-source"}).

Supplementary data associated with this article can be found in the online version at [doi:10.1016/j.dib.2016.02.073](http://dx.doi.org/10.1016/j.dib.2016.02.073){#ir0010}.
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